75979-5
LaboratoryFetal Chromosome 13 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Definition
The interpretation of chromosome 13 aneuploidy (e.g., consistent with diploid, suspected trisomy or consistent with trisomy 13) based on non-invasive prenatal screening methods using cfDNA in maternal plasma.
LOINC 6-Axis Classification
Component
Fetal chromosome 13 trisomy
Property
Imp
Time Aspect
Pt
System
Plas.cfDNA
Scale Type
Ord
Method Type
Dosage of chromosome specific cf DNA
Details
Class
MOLPATH.TRISOMY
Order/Observation
Observation
Short Name
Fet Chr 13 Ts Plas.cfDNA Ql
Display Name
Chr 13 trisomy Dosage of chromosome-specific cfDNA Ql (cfDNA) [Interp]
Related Names
Frequently Asked Questions
What is LOINC code 75979-5?
LOINC code 75979-5 identifies "Fetal Chromosome 13 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative". The interpretation of chromosome 13 aneuploidy (e.g., consistent with diploid, suspected trisomy or consistent with trisomy 13) based on non-invasive prenatal screening methods using cfDNA in maternal plasma.
What does 75979-5 measure?
This code measures Fetal chromosome 13 trisomy in Plas.cfDNA. It belongs to the MOLPATH.TRISOMY class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.